(1s)-m-benzenediol carbonate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (1s)-m-benzenediol carbonate
• 英文别名: m-benzenediol monocarbonate；resorcinol mono-carbonate；m-benzenediol carbonate；resorcinol bicarbonate；resorcinol carbonate；(3-Hydroxyphenyl) hydrogen carbonate
• 化学式: C₇H₆O₄
• 分子量: 154.122
• InChiKey: KNUQTXWYBWMTMP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (1s)-m-benzenediol carbonate 在 potassium carbonate 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 30.0h， 生成
  参考文献：
  名称：

  Ifenprodil-like NMDA receptor modulator based on the biphenyl scaffold

  摘要：

  Ifenprodil-like NMDA receptor negative allosteric modulator based on the biphenyl scaffold has been identified using virtual screening. Docking approach demonstrated that the modulator maintains some characteristic interactions with protein similar to ifenprodil. Electrophysiological and radioligand investigations demonstrated the concentration-dependent NMDA/Gly-induced currents inhibition with IC50 = 5 mu m and significant displacement of [H-3]ifenprodil with EC50 = = 30 mu m, respectively.

  DOI：

  10.1016/j.mencom.2020.05.027

文献信息

• [EN] SYNTHESIS OF RESORCYLIC ACID LACTONES USEFUL AS THERAPEUTIC AGENTS<br/>[FR] SYNTHÈSE DE LACTONES D'ACIDE RÉSORCYLIQUE UTILES EN TANT QU'AGENTS THÉRAPEUTIQUES
  申请人：UNIV STRASBOURG

  公开号：WO2009091921A1

  公开（公告）日：2009-07-23

  Disclosed are macrocyclic compounds of formulae I, I', II, II', III, III', IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.

  公开的是式I、I'、II、II'、III、III'、IV和V的大环化合物，它们是pochonin resorcylic acid lactones的类似物，包括这些化合物的药物组合物，以及包括这些化合物用于治疗由激酶和热休克蛋白90 HSP90介导的疾病的方法和用途。
• Silylated polycarbonate polymers, method of making, and articles
  申请人：Lens Jan Pleun

  公开号：US20080306294A1

  公开（公告）日：2008-12-11

  A silylated dihydroxy aromatic compound of the formula (1a); wherein G a and G b are each independently C 1-12 alkyl, —OSi(C 1-12 alkyl) 3 , C 1-12 arylalkyl, or —OSi(C 1-12 arylalkyl) 3 ; Z a and Z b are each independently a straight or branched C 2-18 alkylene, a C 8-18 arylalkylene, or a C 8-18 alkylarylene, X a is a direct bond, a heteroatom-containing group, or a C 1-18 organic group, and r and s are each independently 1 or 2 is disclosed.

  一种具有式(1a)的硅烷化二羟基芳香族化合物；其中Ga和Gb各自独立地为C1-12烷基、—OSi(C1-12烷基)3、C1-12芳基烷基或—OSi(C1-12芳基烷基)3；Za和Zb各自独立地为直链或支链的C2-18亚烷基、C8-18芳基亚烷基或C8-18烷基芳基亚烷基，Xa为直接键、含杂原子基团或C1-18有机基团，且r和s各自独立地为1或2。
• RESORCYLIC ACID LACTONE COMPOUNDS
  申请人：KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

  公开号：US20140155635A1

  公开（公告）日：2014-06-05

  Disclosed are a novel resorcyclic acid lactone compound with inhibitory activity against protein kinases, a pharmaceutically acceptable salt thereof, a method for the synthesis thereof, and a pharmaceutical composition for the treatment and prevention of various cancer diseases comprising the same as an active ingredient. The novel resorcyclic acid lactone compound is useful as a therapeutic for cancer diseases, especially blood cancer, inter alia, acute myeloid leukemia (AML).

  公开了一种新型对蛋白激酶具有抑制活性的蒽环酸内酯化合物，其药用可接受盐，合成方法以及包含该化合物作为活性成分的治疗和预防各种癌症疾病的药物组合物。这种新型蒽环酸内酯化合物可用作治疗癌症疾病的药物，特别是血癌，例如急性髓细胞白血病（AML）。
• INDANE BISPHENOLS, POLYMERS DERIVED THEREFROM, AND METHODS OF USE THEREOF
  申请人：Schultz Hume Laura G.

  公开号：US20140061533A1

  公开（公告）日：2014-03-06

  Disclosed herein are indane bisphenol monomer units, and polymers derived from such monomer units. Also disclosed herein are blends including such polymers, articles made from such polymers and blends, methods of using such monomers, polymers, and blends, and processes for preparing such monomers, polymers, and blends.

  本发明涉及indane双酚单体单元以及由此类单体单元衍生的聚合物。本发明还涉及包括此类聚合物的混合物，由此类聚合物和混合物制成的物品，使用此类单体、聚合物和混合物的方法，以及制备此类单体、聚合物和混合物的工艺。
• Stabilized thermoplastic composition, method of making, and articles formed therefrom
  申请人：Glasgow Katherine

  公开号：US20070082989A1

  公开（公告）日：2007-04-12

  A thermoplastic composition comprises a polycarbonate, an ionizing radiation stabilizing additive, and a poly-substituted aromatic compound of formula: wherein X is an aryl group; Y is a non-hydrogen substituent group, a is 1 to 4, b is 0 to 4, a+b is less than or equal to 4, and c is 0 or 1; and wherein the amounts and identities of the polycarbonate, ionizing radiation stabilizing additive, and poly-substituted aromatic compound are selected such that a molded article having a thickness of 3.18 millimeters and comprising the thermoplastic composition has, after exposure to gamma radiation at 83 kGy and when measured according to ASTM D1925-70, an increase in yellowness index (dYI) of less than or equal to 50, when compared to the unexposed thermoplastic composition.

  一种热塑性组合物包括聚碳酸酯、电离辐射稳定添加剂和式子为的多取代芳香族化合物：其中X是芳香族基；Y是非氢取代基团，a为1到4，b为0到4，a+b小于或等于4，c为0或1；并且聚碳酸酯、电离辐射稳定添加剂和多取代芳香族化合物的数量和身份被选择为这样的模制品，其厚度为3.18毫米，包含该热塑性组合物，在经过83 kGy的伽马辐射照射后，按照ASTM D1925-70测量，其黄度指数（dYI）增加小于或等于50，与未曝露的热塑性组合物相比。